Renzo Canetta is former vice president of oncology global clinical research at Bristol-Myers Squibb. A graduate of the University of Milan, he is board-certified in clinical and laboratory hematology. He joined Bristol-Myers Squibb in 1980 and held numerous leadership roles there, including head of clinical cancer research and head of development, life cycle management. His experience can be best summarized by the clinical development leading to the acceptance by health authorities and the introduction to the medical practice of 14 new anticancer agents and two new anti-viral drugs. His area of expertise relates to cancer patient care, diagnosis and experimental treatment of hematologic malignancies and solid tumors, methodology of clinical trials, and new drug development. Canetta worked at the Istituto Nazionale Tumori in Milan, Italy, from 1974 to 1980. His research focus was on clinical trials in lymphomas and gastrointestinal tumors.